Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.56 USD | -0.95% | -4.02% | -13.09% |
May. 03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
May. 02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
Financials (USD)
Sales 2024 * | 512M | Sales 2025 * | 627M | Capitalization | 3.45B |
---|---|---|---|---|---|
Net income 2024 * | -560M | Net income 2025 * | -476M | EV / Sales 2024 * | 6.21 x |
Net cash position 2024 * | 274M | Net cash position 2025 * | 337M | EV / Sales 2025 * | 4.97 x |
P/E ratio 2024 * |
-6.33
x | P/E ratio 2025 * |
-7.95
x | Employees | 1,276 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.9% |
Latest transcript on Ultragenyx Pharmaceutical Inc.
1 day | -0.95% | ||
1 week | -4.02% | ||
Current month | -2.30% | ||
1 month | -17.26% | ||
3 months | -8.56% | ||
6 months | +14.59% | ||
Current year | -13.09% |
Managers | Title | Age | Since |
---|---|---|---|
Emil Kakkis
FOU | Founder | 63 | 10-04-21 |
Howard Horn
DFI | Director of Finance/CFO | 47 | 23-10-15 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | - | 17-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Dunsire
BRD | Director/Board Member | 61 | 17-04-05 |
Emil Kakkis
FOU | Founder | 63 | 10-04-21 |
Daniel Welch
CHM | Chairman | 66 | 15-04-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.21% | 0 M€ | -2.17% | - | |
0.82% | 4 M€ | +20.15% | ||
0.43% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 41.56 | -0.95% | 764,567 |
24-05-07 | 41.96 | -2.44% | 842,499 |
24-05-06 | 43.01 | +0.61% | 1,099,857 |
24-05-03 | 42.75 | -1.04% | 1,143,019 |
24-05-02 | 43.2 | -0.23% | 805,187 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.09% | 3.49B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- RARE Stock